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Objectives: To assess the role of intracoronary injection of Na-Nitroprusside in
preventing no-reflow phenomenon in patients with STEMI during primary percutaneous
coronary intervention.
Background: No-reflow constitutes a marker of more extensive myocardial tissue
damage and is associated with poor functional recovery and worse outcome after acute
myocardial infarction.
Method: Sixty patients presented between July 2009 and October 2011 with acute
STEMI eligible for primary PCI were randomized into three groups (20 patients each),
1st group received intracoronary administration of 100 - 300g of Nitroprusside just after
visualization of the vessel distal runoff, a 2nd group received 100 - 300 g of nitroglycerin
and a 3rd group who didn’t receive either Nitroprusside or nitroglycerin (control group).
Assessment of post procedure TIMI flow grading and myocardial blush grading (MBG)
was done.
Results: Na-Nitroprusside group showed a statistically significant better post procedure
TIMI flow and MBG and higher number of patient with post procedure TIMI 3 flow
and MBG 3 than control {18 (90%) vs 9 (45%) p value 0.018)} respectively, {10 (50%)
vs 4 (20%)p value 0.0221} respectively and a statistically non significant better post
procedure TIMI flow and MBG with higher number of patients with post procedure
TIMI 3 flow and MBG 3 when compared to those who received intracoronary
nitroglycerin (p value 0.05).
Conclusion: Intracoronary injection of Na-Nitroprusside prevent no-reflow phenome-
non and improve post procedure TIMI flow and MBG in patients with STEMI during
primary percutaneous coronary intervention.
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Objectives: Some studies showed that diabetic patients (D) group (DG) had a worse
outcome when compared to nondiabetic (ND) patients group (NDG), after primary
percutaneous coronary intervention (PCI). The objectives were to compare mortality and
major coronary events (MACE) at 30 days and 1 year of DG and NDG submitted to
primary PCI and to study whether another conditions were related to worst outcome of
patients in 30 days or one year.
Methods: Prospective study with 450 consecutive patients submitted to PCI from
01/01/2001 to 12/31/2006 (121 D and 329 ND) with ST-segment elevation acute
myocardial infarction (AMI) in the first 12 hours of symptoms presentation treated with
balloon catheter or bare metal stent and without cardiogenic shock. We used in statistical
analysis: Student t test, chi-square test, Fischer exact test, and multivariate analysis: logistic
regression and Cox analysis.
Results: DG and NDG had similar age (63.110.0 and 62.3 11.7 years, p0.443),
male gender (63.6% and 69.9%, p0.205) and multivascular disease (66.1% and 60.8%,
p0.301). The diabetic group had more dyslipidemia (65.3%  51.7%, p0.009) and
severe left ventricular dysfunction (15.7% 8.2%, p0.019). The stent implantation rate
was (83.5% and 81.1%, p0.863) and glycoprotein (GP) IIb/IIIa inhibitors utilization
(79.3% and 82.2%, p0.831) were similar. The mortality at 30 days (2.5% and 2.7%,
p1.000) and at 1 year (5.0% and 6.7%, p0,650) and MACE at 30 days (4.1% and
6.4%, p0,496) and at 1 year (19.4% and 15.4%, p0,3492) were similar. The absence
of TIMI III flow after the procedure (procedure failure) was the only independent hospital
mortality (30 days) predictor (P0,001, OR8,045, CI95 2,327-27,816). Procedure
failure (p0,023, HR3,364, CI95 1,182-9,578) and age  65 years (P0,035,
HR3,391, CI95 1,091-10,543) were independent predictors of mortality at 1 year. The
multivessel coronary disease (p0,023, OR4,218, CI95 1,223-14,545 and procedure
failure (P0,028, OR 3.155, CI95 1,132-8,799) were independent predictors of MACE
at 30 days and multivessel coronary disease was independent of MACE at 1 year
(p0.034, HR1.854, CI95 1.048-3.280).
Conclusions: The diabetic patients submitted to primary PCI had mortality rate and
MACE similar to none diabetic patients at 30 days and 1 year. The absence of TIMI III flow
were predictor of mortality at 30 days and 1 year and age  65 years at 1 year. Independent
predictors of MACE at 30 days were multivessel coronary disease and absence of TIMI III
flow (procedure failure) and at 1 year was multivessel coronary disease.
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Background: Atrial fibrillation has been known for a predictor of poor prognosis in
myocardial infarction. We assessed the impact of the CHADS2 and CHA2DS2-VASc
score on prognosis in patients with atrial fibrillation combined with acute myocardial
infarction (AMI) treated invasively.
Methods: We analyzed 10,482 patients, who have been followed up for over 12 months,
among 13,901 patients registered in the Korea Acute Myocardial Infarction Registry
between November 2005 and December 2006. CHADS2 and CHA2DS2-VASc score
were defined according to ESC2010 guideline.
Results: AF was recognized in 423 patients (4.0%); the remaining 10,059 patients
(96.0%) were free of atrial fibrillation. For patients with or without atrial fibrillation,
univariate analysis showed that components of CHA2DS2-VASc score and metabolic
syndrome were associated with high one year composite MACE. Multivariate analysis
showed that heart failure, age 75, diabetes, CVD, multivessel involvement were
associated with high one year composite MACE. When CHADS2 was equal or greater
than 2, it could predict one year cardiac death (95% CI: 2.095-2.562, p  0.001,
Sensitivity 63.2%, Specificity 66.6%, AUC 0.680). When CHA2DS2-VASc was equal or
greater than 3, it could predict one year cardiac death (95% CI: 2.235-2.742, p  0.001,
Sensitivity 74.4%, Specificity 59.6%, AUC 0.723). For patients with atrial fibrillation,
univariate analysis showed that heart failure, age75, cerebrovascular event, Low
HDL-cholesterol, multivessel involvement were associated with high one year composite
MACE. Multivariate analysis showed that heart failure, age 75, CVD, multivessel
involvement were associated with high one year composite MACE. When CHADS2 was
equal or greater than 2, it could predict one year cardiac death (95% CI: 1.840-4.730,
p  0.001, Sensitivity 71.3%, Specificity 54.3%, AUC 0.649). When CHA2DS2-VASc
was equal or greater than 3, it could predict one year cardiac death (95% CI: 1.934-5.536,
p  0.001, Sensitivity 80.6%, Specificity 44.1%, AUC 0.653).
Conclusions: In patients with or without atrial fibrillation, CHADS2 and CHA2DS2-
VASc score demonstrated significant value in its predictive accuracy for 1-year mortality
in patient with acute myocardial infarction. CHADS2 and CHA2DS2-VASc score for
patients with acute myocardial infarction is a simple and good risk scoring system in
prediction of 1-year mortality.
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Objectives: The goal of this study is to investigate baseline risk factors, angiographic
characteristics, interventional procedural information and hospital outcomes in patients
with acute myocardial infarction (AMI) treated with percutaneous coronary intervention
(PCI) according to insurance status.
Background: Recent studies demonstrate that patients with government-sponsored
insurance and no insurance have worse cardiovascular outcomes than patients with private
insurance after PCI. Additionally, insurance status has a significant impact in the decision
to use drug-eluting or bare-metal stents. The effect of insurance type in patients
undergoing PCI for the treatment of AMI is not known.
Methods: Baseline demographics, clinical characteristics, PCI procedural information
and hospital outcomes were investigated in 771patients with AMI (STEMI and
NSTEMI) treated at the Los Angeles County Hospital  USC Medical Center
and Keck Medical Center of USC between January 2008 and June 2011. Patients were
divided into 3 groups according to insurance type: Uninsured (n301), government
sponsored (n 399, including Medicare and Medicaid), and private (n71).
Results: Uninsured compared to government sponsored and private insurance patients
were younger (54.27.5 vs. 62.712 vs. 58.210.9, p0.0001), more likely Hispanic
(59.8% vs. 17.95% vs. 33.8%, p0.0001), had higher total cholesterol (189.556 vs.
163.847 vs. 175.354.1 mg/dL, p0.0001), more likely to have metabolic syndrome
(54.5% vs. 42.5% vs. 50%, p0.05), and had lower rates of renal insufficiency (2.1% vs.
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10.8% vs. 12.1%, p0.0001). There was no difference in DES use between the groups
(46.7% vs. 42.7% vs. 43.4%, p0.84). Cardiogenic shock on presentation (14.8% vs.
12.8% vs. 4.7%, p0.0001), and in-hospital mortality (7.9% vs. 6.4% vs. 1.8%, p0.001)
were highest in the government-sponsored group followed by private and uninsured
groups.
Conclusion: This study demonstrates that insurance type is associated with significant
differences at baseline (clinical, demographic and procedural characteristics) and hospital
outcomes in patients with AMI with PCI.
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Background: The goal of the study is to investigate baseline risk factors, coronary artery
angiogram results and interventions, and hospital outcomes in young patients with acute
myocardial infarction (less than 45 years vs. older than 45 years of age).
Method: Retrospective analysis of 779 patients treated with PCI for acute myocardial
infarction (AMI) at the Los Angeles County Hospital USC Medical Center and Keck
Medical Center of USC between January 2008 and June 2011. Patients were divided into
2 groups according to age 81 young patients and 698 older patients. Baseline demograph-
ics, clinical characteristics, coronary angiogram results, PCI procedural information and
hospital outcomes were compared.
Results: Young patients ( 45 years old) represented 10.3% (n81) of the total patient
population (779 patients). Younger patients were found to have lower rates of diabetes
(22.2% vs. 35.6%, p-value 0.03), more likely to be males (87.6% vs. 76%, p-value 0.02) and
have higher triglyceride levels (212 mg/dl vs. 153.4 mg/dl, p-value 0.014). Young patients
were less likely to have hypertension (41.8% vs. 66.8%, p-value  0.0001). Both groups
had similar rates of NSTEMI (44.4% vs. 49.7%, p-value 0.37) and STEMI (55.6% vs.
50.3%, p-value 0.37). Single vessel coronary artery disease was more prevalent in the
younger group (71.7% vs. 44.6%, p-value0.001) and had a higher rate of total occlusion
of the infarct-related artery (39.7% vs. 19.1%, p-value 0.003). Rates of percutaneous
coronary artery interventions (97.5% vs. 94%, p-value 0.3) and number coronary artery
stent placement (1.5 vs. 1.8, p-value 0.26) were similar between both groups, while the
younger group had a lower rate of post-intervention acute renal failure (1.4% vs. 9.5%,
p-value 0.02). Length of total hospital stay (4.6 days vs. 6 days, p-value 0.15) and intensive
care unit stay (2.9 days vs. 3.6 days, p-value 0.32) was also similar.
Conclusion: Younger age in patients with AMI is associated with male predom-
inance, higher triglyceride levels, and higher rates of single vessel disease and total
occlusion of the infarct related artery. Younger patients had a lower rate of
post-procedure renal failure, while the remaining post-procedural outcomes and
in-hospital mortality were similar.
CRT-26
Chronic Pretreatment of Angiotensin Converting Enzyme Inhibitor Decreases
In-hospital Adverse Events in Diabetic Hypertensive Patients with Acute Myocardial
Infarction
Seo Na Hong,1 Nam Sik Yoon,2 Youngkeun Ahn,2 Myung Ho Jeong2
1Seonam university hospital, Gwangju, Korea, Republic of 2Chonnam national
university hospital, Gwangju, Korea, Republic of
Background: Angiotensin converting enzyme inhibitor (ACEI) or angiotensin
receptor blocker was commonly used in patients who have hypertension and
diabetes. The aim of this study was to evaluate the effect of chronic pretreatment
of ACEI or ARB before development of acute myocardial infraction (AMI) for in
hospital outcome after AMI.
Methods: A total of 1369 diabetic-hypertensive patients (66.710.8 years, male 59.2 %)
with AMI (739 ST segment elevation MI and 630 non-ST segment elevation MI) who
were registered in Korea Acute Myocardial Infarction Registry from Nov. 2005 to Aug
2007. were enrolled. We excluded patients with chronic renal failure and chronic heart
failure. The patients were divided into three groups: the patients with chronic pretreat-
ment of ACEI (group I, n148), the patients with chronic pretreatment of ARB (group
II, n175), and patients without pretreatment of ACEI or ARB (group III, n1046).
The clinical characteristics and in-hospital adverse events (IHAEs) were compared among
the groups.
Results: The baseline clinical characteristics were similar among three groups including
clinical diagnosis, Killip class, laboratory parameters, strategy of treatment and angio-
graphic findings. The group I had the lowest rate of IHAEs among the groups (group I:
9.2% vs. group II: 24.8% vs. group III: 17.6%, p0.010). As compared with the group III,
the group I had significantly lower rate of IHAEs (9.2% vs. 17.6%, p0.003), but group
II had significantly higher rate of IHAEs (24.8% vs. 17.6%, p0.049). In Cox
proportional hazard regression analysis, chronic pretreatment of ACEI (RR: 0.474, 95%
CI 0.234-0.958, p0.037) and ARB (RR: 3.261, 95% CI 1.470-7.234, p0.004) were
associated with IHAEs in diabetic hypertensive patient with AMI.
Conclusion: Chronic pretreatment of ACEI decreases IHAEs but that of ARB
increases IHAEs in diabetic hypertensive patient with AMI.
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Background: Insulin resistance (IR) is an associated with a significant increase in the risk
of coronary artery disease. The serum Apolipoprotein B (Apo B) and Apo B/Apo-I ratio
are important markers of IR in non-diabetic, normoglycemic subjects. We investigated
the role of Apo B and ApoB/Apo A1 ratio in patients with acute Non-ST elevation
myocardial infarction (NSTEMI) with total occlusion (TO) of infarct-related artery
(IRA).
Methods: A total of 280 patients (64.512.7 years, male 70 %) with acute NSTEMI
who were underwent percutaneous coronary intervention were enrolled. We excluded
patients with history of diabetes, or medication of oral hypoglycemics, or hemoglobin A1c
(HbA1c) more than 6.5%. The patients were divided into two groups according to the
finding of IRA (Group I: patients with TO of IRA, n84; Group II: patients with
non-TO of IRA, n196).
Results: The level of troponin I are significantly higher in Group I than in Group II
(83.330.1 vs. 71.633.7 ng/mL, p0.044). Most frequent IRA was left circumflex
artery in Group I (50%) and Group I had more complex vascular lesion compared with
Group II (Type C lesion 64.3% vs. 29.0%, p0.001). The level of Apo B and Apo B/Apo
A1 ratio were significantly higher in Group I than in Group II (108.125.3 vs.
96.325.4, p0.019; 0.870.21 vs. 0.740.22, p0.004, respectively). Group I was
divided into two subgroups according to initial therapeutic strategy. In subgroup analysis,
early invasive treatment group had lower in-hospital adverse events than in early
conservative treatment group (5.7% vs. 10.1%, p0.046). In multivariate analysis, elevated
Apo B/Apo A1 ratio showed high probability of TO of IRA (odd ratio, 3.56; 95% CI,
1.12 to 11.38, p0.031).
Conclusions: The level of Apo B and Apo B/Apo A1 ratio were associated TO of IRA
in patients with acute NSTEMI. The markers may be useful for choice of initial
therapeutic strategy in acute NSTEMI.
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What Are The Correlates For Mortality In Patients Presented With Acute Myocardial
Infarct Complicated By Cardiogenic Shock?
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Introduction: Acute myocardial infarction (AMI) complicated by cardiogenic shock
(CS) is associated with high mortality rates. This study aimed to explore the correlates for
mortality in patients presented in CS complicating an AMI who were treated with
primary percutaneous intervention (PPCI) and intra-aortic balloon pump counterpulsa-
tion (IABP).
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